What is the study about?
COMPASS-ND is Canada’s largest dementia study that aims to better understand various cognitive conditions in the aging population. For the first time, this study will integrate a wide range of measures (e.g. clinical, neuropsychological, imaging data) to address the causes, diagnosis, management, treatment, and prevention of these conditions.
Eligibility–Who can participate?
- Be 50-90 years of age (or 60-90 years of age if in the healthy volunteer, subjective cognitive impairment, mild cognitive impairment (MCI), or vascular MCI groups)
- Have memory conditions (i.e., subjective cognitive impairment, mild cognitive impairment (MCI), subcortical ischemic vascular MCI, mild Alzheimer’s disease, dementia of mixed etiology, Lewy Body disease, Parkinson’s dementia/MCI and frontotemporal dementia), or be a healthy volunteer
- Have a study partner who must have regular contact with the participant (at least one interaction per week). The study partner will be asked to provide information and accompany the patient to all visits
- 4-6 visits over 3 months, with follow-up visits at 1 and 2 years
- Annual telephone checks will be conducted and the baseline procedures may be repeated after 2 years
- Visits will include cognitive testing, questionnaires, biosample collection, MRI, neurological and physical exams
Drs. Sandra Black, Carmela Tartaglia
BaycrestSunnybrook Health Sciences CentreUniversity Health Network (UHN)-Toronto Western Hospital
Alzheimer’s disease, Dementia with Lewy bodies (DLB), Frontotemporal dementia (FTD), Healthy volunteer, Lewy Body Dementia (LBD), Mild cognitive impairment, Parkinson /Lewy body spectrum disease, Parkinson's disease dementia, Vascular Cognitive Impairment, Vascular dementia